Octagon Capital Advisors LP Quant / Systematic

Location: New York, NY

CIK: 0001839435 · Show all filings

Period: Q1 2021 (← Previous) (Next →)

Filing Date: May 17, 2021

Total Value: $265M (100.0% shares, 0.0% debt)

Holdings (28)

Value $25.69M Shares 530,050 Est. Cost $47.34 Unrealized —

— CURIS INC 9.1%

Value $24.09M Shares 2,128,400 Est. Cost $8.19 Unrealized —

APLS APELLIS PHARMACEUTICALS INC 8.9%

Value $23.53M Shares 548,374 Est. Cost $42.30 Unrealized +11.9%

FDMT 4D MOLECULAR THERAPEUTICS IN 6.2%

Value $16.41M Shares 378,288 Est. Cost $41.28 Unrealized +7.3%

— ACCELERON PHARMA INC 5.7%

Value $15.24M Shares 112,363 Est. Cost $127.94 Unrealized —

GOSS GOSSAMER BIO INC 4.9%

Value $13.07M Shares 1,413,138 Est. Cost $9.85 Unrealized +2.4%

ARVN ARVINAS INC 4.4%

Value $11.8M Shares 178,500 Est. Cost $34.48 Unrealized +121.8%

CLDX CELLDEX THERAPEUTICS INC NEW 4.4%

Value $11.56M Shares 561,398 Est. Cost $18.00 Unrealized +27.6%

— IKENA ONCOLOGY INC 4.3%

Value $11.3M Shares 400,000 Est. Cost $28.25 Unrealized —

RCUS ARCUS BIOSCIENCES INC 4.2%

Value $11.23M Shares 400,000 Est. Cost $26.85 Unrealized +29.6%

RNAM AVIDITY BIOSCIENCES INC 3.7%

Value $9.741M Shares 446,641 Est. Cost $28.99 Unrealized -15.5%

DYN DYNE THERAPEUTICS INC 3.4%

Value $9.064M Shares 583,649 Est. Cost $19.71 Unrealized -1.8%

PMVP PMV PHARMACEUTICALS INC 3.1%

Value $8.223M Shares 250,000 Est. Cost $39.23 Unrealized +0.5%

— CHEMOCENTRYX INC 2.9%

Value $7.69M Shares 150,076 Est. Cost $61.92 Unrealized —

DSGN DESIGN THERAPEUTICS INC 2.8%

Value $7.475M Shares 250,000 Est. Cost $31.14 Unrealized 0.0%

— CONNECT BIOPHARMA HLDGS LTD 2.6%

Value $6.91M Shares 373,492 Est. Cost $18.50 Unrealized —

TSHA TAYSHA GENE THERAPIES INC 2.5%

Value $6.505M Shares 320,440 Est. Cost $21.54 Unrealized +25.7%

CRDF CARDIFF ONCOLOGY INC 2.3%

Value $6.019M Shares 650,000 Est. Cost $17.58 Unrealized -30.9%

— NGM BIOPHARMACEUTICALS INC 2.2%

Value $5.814M Shares 200,000 Est. Cost $29.53 Unrealized —

RVMD REVOLUTION MEDICINES INC 2.2%

Value $5.787M Shares 126,136 Est. Cost $39.54 Unrealized +13.4%

— KRONOS BIO INC 1.6%

Value $4.278M Shares 146,173 Est. Cost $29.87 Unrealized —

— IVERIC BIO INC 1.6%

Value $4.203M Shares 680,036 Est. Cost $6.91 Unrealized —

— MERUS N V 1.6%

Value $4.178M Shares 200,000 Est. Cost $20.89 Unrealized —

MLTX HELIX ACQUISITION CORP 1.5%

Value $4.08M Shares 400,000 Est. Cost $11.37 Unrealized —

EWTX EDGEWISE THERAPEUTICS INC 1.5%

Value $4.063M Shares 125,000 Est. Cost $32.43 Unrealized 0.0%

— PROMETHEUS BIOSCIENCES INC 1.4%

Value $3.652M Shares 200,000 Est. Cost $18.26 Unrealized —

— JIYA ACQUISITION CORP 1.1%

Value $2.952M Shares 300,000 Est. Cost $10.30 Unrealized —

FHTX FOGHORN THERAPEUTICS INC 0.3%

Value $911K Shares 69,132 Est. Cost $16.39 Unrealized 0.0%

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
NBP	I MAB	530,050	$25.69M	9.7%	$47.34	—	SPONSORED ADS	44975P103
—	CURIS INC	2,128,400	$24.09M	9.1%	$8.19	—	COM NEW	231269200
APLS	APELLIS PHARMACEUTICALS INC	548,374	$23.53M	8.9%	$42.30	+11.9%	COM	03753U106
FDMT	4D MOLECULAR THERAPEUTICS IN	378,288	$16.41M	6.2%	$41.28	+7.3%	COM	35104E100
—	ACCELERON PHARMA INC	112,363	$15.24M	5.7%	$127.94	—	COM	00434H108
GOSS	GOSSAMER BIO INC	1,413,138	$13.07M	4.9%	$9.85	+2.4%	COM	38341P102
ARVN	ARVINAS INC	178,500	$11.8M	4.4%	$34.48	+121.8%	COM	04335A105
CLDX	CELLDEX THERAPEUTICS INC NEW	561,398	$11.56M	4.4%	$18.00	+27.6%	COM NEW	15117B202
—	IKENA ONCOLOGY INC	400,000	$11.3M	4.3%	$28.25	—	COM	45175G108
RCUS	ARCUS BIOSCIENCES INC	400,000	$11.23M	4.2%	$26.85	+29.6%	COM	03969F109
RNAM	AVIDITY BIOSCIENCES INC	446,641	$9.741M	3.7%	$28.99	-15.5%	COM	05370A108
DYN	DYNE THERAPEUTICS INC	583,649	$9.064M	3.4%	$19.71	-1.8%	COM	26818M108
PMVP	PMV PHARMACEUTICALS INC	250,000	$8.223M	3.1%	$39.23	+0.5%	COM	69353Y103
—	CHEMOCENTRYX INC	150,076	$7.69M	2.9%	$61.92	—	COM	16383L106
DSGN	DESIGN THERAPEUTICS INC	250,000	$7.475M	2.8%	$31.14	0.0%	COM	25056L103
—	CONNECT BIOPHARMA HLDGS LTD	373,492	$6.91M	2.6%	$18.50	—	ADS	207523101
TSHA	TAYSHA GENE THERAPIES INC	320,440	$6.505M	2.5%	$21.54	+25.7%	COM SHS	877619106
CRDF	CARDIFF ONCOLOGY INC	650,000	$6.019M	2.3%	$17.58	-30.9%	COM	14147L108
—	NGM BIOPHARMACEUTICALS INC	200,000	$5.814M	2.2%	$29.53	—	COM	62921N105
RVMD	REVOLUTION MEDICINES INC	126,136	$5.787M	2.2%	$39.54	+13.4%	COM	76155X100
—	KRONOS BIO INC	146,173	$4.278M	1.6%	$29.87	—	COM	50107A104
—	IVERIC BIO INC	680,036	$4.203M	1.6%	$6.91	—	COM	46583P102
—	MERUS N V	200,000	$4.178M	1.6%	$20.89	—	COM	N5749R100
MLTX	HELIX ACQUISITION CORP	400,000	$4.08M	1.5%	$11.37	—	COM CL A	G4444C102
EWTX	EDGEWISE THERAPEUTICS INC	125,000	$4.063M	1.5%	$32.43	0.0%	COM	28036F105
—	PROMETHEUS BIOSCIENCES INC	200,000	$3.652M	1.4%	$18.26	—	COM	74349U108
—	JIYA ACQUISITION CORP	300,000	$2.952M	1.1%	$10.30	—	COM CL A	47760M102
FHTX	FOGHORN THERAPEUTICS INC	69,132	$911K	0.3%	$16.39	0.0%	COM	344174107